Is Monopar Therapeutics Inc (MNPR) Stock a Smart Value Tuesday?

Monopar Therapeutics Inc (MNPR) is around the top of the Healthcare sector according to InvestorsObserver. MNPR received an overall rating of 33, which means that it scores higher than 33% of stocks. Additionally, Monopar Therapeutics Inc scored a 90 in the Healthcare sector, ranking it higher than 90% of stocks in that sector.

MNPR has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on MNPR!

See Full MNPR Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Monopar Therapeutics Inc Stock Today?

Monopar Therapeutics Inc (MNPR) stock has gained 17.15% while the S&P 500 is lower by -0.68% as of 10:18 AM on Tuesday, Mar 5. MNPR has gained $0.17 from the previous closing price of $0.99 on volume of 1,053,344 shares. Over the past year the S&P 500 has risen 25.88% while MNPR is lower by -61.46%. MNPR lost -$0.71 per share the over the last 12 months. Click Here to get the full Stock Report for Monopar Therapeutics Inc stock.